688136.SH
Kexing Biopharm Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 19.59
+3.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 30.68x
- P/E 2027E
- 22.64x
- P/E 2028E
- 16.98x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.44x
- PEG TTM
- —
- Price / book
- 2.15x
- Price / sales
- 2.63x
- Price / cash flow
- 56.91x
Enterprise value
- Enterprise value
- CNY 4.1B
- EV / sales
- 2.81x
- EV / EBITDA
- 15.06x
- EV / EBIT
- 37.84x
- Market cap
- CNY 4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026